Kati Erdmann

2.6k total citations · 1 hit paper
59 papers, 2.0k citations indexed

About

Kati Erdmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Kati Erdmann has authored 59 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 19 papers in Oncology. Recurrent topics in Kati Erdmann's work include Renal cell carcinoma treatment (10 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers) and Prostate Cancer Treatment and Research (8 papers). Kati Erdmann is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Heme Oxygenase-1 and Carbon Monoxide (9 papers) and Prostate Cancer Treatment and Research (8 papers). Kati Erdmann collaborates with scholars based in Germany, United States and United Kingdom. Kati Erdmann's co-authors include H. Schröder, Belinda W.Y. Cheung, Nina Grosser, Susanne Fuessel, Manfred P. Wirth, Georg Berndt, Stephan Immenschuh, Anna Dubrovska, Lorenz C. Hofbauer and Martina Rauner and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Kati Erdmann

58 papers receiving 2.0k citations

Hit Papers

The possible roles of food-derived bioactive peptides in ... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kati Erdmann Germany 22 1.3k 361 289 274 223 59 2.0k
Xinyu Yang China 23 1.2k 0.9× 188 0.5× 193 0.7× 134 0.5× 233 1.0× 97 2.4k
Hsing‐Chun Kuo Taiwan 30 1.1k 0.8× 313 0.9× 246 0.9× 207 0.8× 112 0.5× 84 2.5k
Zhiqiang Huang China 30 764 0.6× 140 0.4× 344 1.2× 272 1.0× 227 1.0× 140 2.4k
Mohamed F. Elshal Egypt 22 832 0.6× 277 0.8× 567 2.0× 158 0.6× 92 0.4× 70 2.4k
Seung Hyun Oh South Korea 30 1.4k 1.1× 440 1.2× 402 1.4× 228 0.8× 101 0.5× 100 2.6k
Young Do Yoo South Korea 25 1.6k 1.2× 363 1.0× 272 0.9× 209 0.8× 230 1.0× 54 2.6k
Jun‐Jen Liu Taiwan 23 783 0.6× 205 0.6× 181 0.6× 84 0.3× 90 0.4× 49 1.6k
Youwei Zhang China 30 2.3k 1.8× 1.0k 2.8× 574 2.0× 293 1.1× 81 0.4× 87 3.1k
Zhuang Yu China 28 1.3k 1.0× 543 1.5× 429 1.5× 428 1.6× 136 0.6× 144 2.4k

Countries citing papers authored by Kati Erdmann

Since Specialization
Citations

This map shows the geographic impact of Kati Erdmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kati Erdmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kati Erdmann more than expected).

Fields of papers citing papers by Kati Erdmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kati Erdmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kati Erdmann. The network helps show where Kati Erdmann may publish in the future.

Co-authorship network of co-authors of Kati Erdmann

This figure shows the co-authorship network connecting the top 25 collaborators of Kati Erdmann. A scholar is included among the top collaborators of Kati Erdmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kati Erdmann. Kati Erdmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Cristina Cano, Benedikt Hoeh, Séverine Banek, et al.. (2024). First-Line Immune Combination Therapies for Nonclear Cell Versus Clear Cell Metastatic Renal Cell Carcinoma: Real-World Multicenter Data From Germany. Clinical Genitourinary Cancer. 22(4). 102112–102112. 3 indexed citations
2.
Grützmann, Konrad, Karsten Salomo, Alexander Krüger, et al.. (2024). Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesicles. Biology Direct. 19(1). 38–38. 10 indexed citations
5.
Peitzsch, Claudia, et al.. (2022). Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. International Journal of Molecular Sciences. 24(1). 666–666. 12 indexed citations
6.
Thomas, Christian, Martin Baunacke, Holger H.H. Erb, et al.. (2021). Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?. Cancers. 14(1). 8–8. 11 indexed citations
7.
Mendus, Diana, Ralf A. Hilger, Trudy G. Oliver, et al.. (2020). Diphenhydramine increases the therapeutic window for platinum drugs by simultaneously sensitizing tumor cells and protecting normal cells. Molecular Oncology. 14(4). 686–703. 7 indexed citations
8.
Rachner, Tilman D., Sabine Kasimir‐Bauer, Andy Göbel, et al.. (2018). Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer. Clinical Cancer Research. 25(4). 1369–1378. 29 indexed citations
9.
Hampel, Silke, et al.. (2017). Systematic evaluation of oligodeoxynucleotide binding and hybridization to modified multi-walled carbon nanotubes. Journal of Nanobiotechnology. 15(1). 53–53. 7 indexed citations
10.
Erdmann, Kati, et al.. (2016). MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. Journal of Cancer Research and Clinical Oncology. 142(11). 2249–2261. 33 indexed citations
11.
Cojoc, Monica, Claudia Peitzsch, Ina Kurth, et al.. (2015). Aldehyde Dehydrogenase Is Regulated by β-Catenin/TCF and Promotes Radioresistance in Prostate Cancer Progenitor Cells. Cancer Research. 75(7). 1482–1494. 187 indexed citations
12.
Toma, Marieta, Rebekka Wehner, Georgia Fodelianaki, et al.. (2015). Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. OncoImmunology. 4(6). e1008342–e1008342. 16 indexed citations
13.
Fuessel, Susanne, Kati Erdmann, Helge Täubert, et al.. (2014). Prognostic impact of urokinase-type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis. BMC Cancer. 14(1). 974–974. 12 indexed citations
14.
Grosser, Nina, et al.. (2010). Simvastatin-dependent up-regulation of heme oxygenase-1 via mRNA stabilization in human endothelial cells. European Journal of Pharmaceutical Sciences. 41(1). 118–124. 32 indexed citations
15.
Schulz, Stephanie, Kati Erdmann, Ronald J. Wong, et al.. (2009). Molecular mechanism and functional consequences of lansoprazole-mediated heme oxygenase-1 induction. World Journal of Gastroenterology. 15(35). 4392–4392. 14 indexed citations
16.
Wiederholt, T., Ruth Heise, Claudia Skazik, et al.. (2009). Calcium pantothenate modulates gene expression in proliferating human dermal fibroblasts. Experimental Dermatology. 18(11). 969–978. 41 indexed citations
17.
Erdmann, Kati, Belinda W.Y. Cheung, Stephan Immenschuh, & H. Schröder. (2008). Heme oxygenase-1 is a novel target and antioxidant mediator of S-adenosylmethionine. Biochemical and Biophysical Research Communications. 368(4). 937–941. 18 indexed citations
18.
Erdmann, Kati, et al.. (2006). The ACE Inhibitory Dipeptide Met-Tyr Diminishes Free Radical Formation in Human Endothelial Cells via Induction of Heme Oxygenase-1 and Ferritin. Journal of Nutrition. 136(8). 2148–2152. 88 indexed citations
19.
Becker, Jan C., Nina Grosser, Stephanie Schulz, et al.. (2006). Beyond gastric acid reduction: Proton pump inhibitors induce heme oxygenase-1 in gastric and endothelial cells. Biochemical and Biophysical Research Communications. 345(3). 1014–1021. 66 indexed citations
20.
Grosser, Nina, et al.. (2004). Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochemical and Biophysical Research Communications. 325(3). 871–876. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026